Vimarsana
Biggest News Aggregation in the World

Mitsuro Kanda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mitsuro Kanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mitsuro Kanda Today - Breaking & Trending Today

SDF-4 protein shows promise for early detection of gastric cancer - Vimarsana News

SDF-4 protein shows promise for early detection of gastric cancer

Published: November 10, 2023

A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker.

Source: news-medical.net
Related Topics:
Takahiro ShinozukaMitsuro KandaYasuhiro KoderaNagoya UniversityNagoya University Graduate School Of MedicineNagoya University Graduate SchoolProfessor Yasuhiro KoderaGastric CancerPancreatic Cancer
Ymmunobio Welcomes Dr. Kanda and Dr. Khairnar to Advisory Board - Vimarsana News

Ymmunobio Welcomes Dr. Kanda and Dr. Khairnar to Advisory Board

Published: March 2, 2023

BioPharma

Source: biopharmadive.com
Related Topics:
Basel StadtUnited StatesVishal KhairnarMitsuro KandaKatrin RupallaJohns Hopkins UniversityAnnals Of Cancer ResearchGastroenterology ResearchCytovia Therapeutics IncUniversity Of DuisburgDepartment Of Gastroenterological SurgeryNagoya UniversityDepartment Of PathologyUniversity Of Nagoya School MedicineAssistant ProfessorGastroenterological SurgeryNagoya University Graduate SchoolSenior ScientistCytovia TherapeuticsYmmunobio AdvisoryNagoya SchoolGastric CancerCancer ResearchMeeting Scholar In Training AwardJohns Hopkins
Ymmunobio Appoints Dr. Caroline Germa to Board of Directors - Vimarsana News

Ymmunobio Appoints Dr. Caroline Germa to Board of Directors

Published: February 16, 2023

BioPharma

Source: biopharmadive.com
Related Topics:
Basel StadtFrance GeneralMitsuro KandaKatrin RupallaCaroline GermaNagoya UniversityDepartment Of Gastroenterological SurgeryLille UniversityEarly Development Clinical Group For AstrazenecaDevelopment TeamBristol Myers SquibbYmmunobio FounderChief Medical OfficerEarly Development Clinical GroupVice PresidentDevelopment Team LeadBreast DiseaseImmunology MasterProfessor Mitsuro KandaGastroenterological Surgery
Ymmunobio Signs Transfer Ownership Agreement with Nagoya University for NPTXR Antibodies - Vimarsana News

Ymmunobio Signs Transfer Ownership Agreement with Nagoya University for NPTXR Antibodies

Published: January 31, 2023

/PRNewswire/ -- Ymmunobio AG, a preclinical stage biotech company specializing in the development of innovative treatments for cancer patients, has secured...

Source: prnewswire.com
Related Topics:
Basel StadtMitsuro KandaKatrin RupallaWorld Cancer Fund InternationalNagoya UniversityDepartment Of Gastroenterological SurgeryNational Library Of MedicineProfessor Mitsuro KandaGastroenterological SurgeryYmmunobio FounderWorld Cancer FundNational LibraryHealth Care Amp HospitalsMedical Pharmaceuticals Pharmaceuticals